LAMEA Neuromodulation Market Size, Share & Industry Trends Analysis Report By Technology (Internal and External), By Biomaterial, By Application, By Country and Growth Forecast, 2022 - 2028

The Latin America, Middle East and Africa Neuromodulation Market would witness Market growth of 7.9% CAGR during the forecast period (2022-2028).

By modifying faulty neural pathway behavior induced by the disease process, neuromodulation devices stimulate nerves with pharmacological drugs, electrical signals, or other sources of energy. Deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), and spinal cord stimulation are examples of neuromodulation devices (SCS). These neuromodulation devices are used to treat tremor, urine and fecal incontinence, and dystonia, among other neurological problems.

Neuromodulation works by stimulating nerves to cause a biological response or by applying modest dosages of specific pharmacological drugs directly to the area of action. Electrodes are applied to the spinal cord, brain, or peripheral nerves in neurostimulation devices. The rising base of people suffering from various conditions such as urine incontinence, Parkinson's disease, spinal cord damage, migraine, and epilepsy is fueling the neuromodulation Market growth.

There is a robust prevalence of numerous major Market players across this region. In order to survive this cut-throat competition, these players are majorly expediting their efforts on bringing new innovations across the Market . Increased rates and prevalence of neurological illnesses, rapid population aging, development of improved neurostimulation technologies, and increased awareness are some of the key factors driving the internal neuromodulation technologies Market in Saudi Arabia, South Africa, and Turkey. Emerging markets like Saudi Arabia, South Africa, and Turkey have gained the traction of companies working on internal neuromodulation implant development and marketing. The demand for internal neuromodulation technologies in these expanding Market segments is being driven by growth in neurological illnesses and government measures to raise awareness through education campaigns.

The Brazil Market dominated the LAMEA Neuromodulation Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $59.1 million by 2028. The Argentina Market is poised to grow at a CAGR of 8.5% during (2022 - 2028). Additionally, The UAE Market would witness a CAGR of 7.6% during (2022 - 2028).

Based on Technology, the Market is segmented into Internal and External. Based on Biomaterial, the Market is segmented into Metallic, Polymeric, and Ceramic. Based on Application, the Market is segmented into Chronic Pain, Urinary & Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, and Others. Based on countries, the Market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Neuromodulation Market is Predict to reach $3.8 Billion by 2028, at a CAGR of 6%

The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, NeuroSigma, Inc., NeuroPace, Inc., Neuronetics, Inc., MicroTransponder Inc., and Bioventus Inc.

Scope of the Study

Market Segments Covered in the Report:

By Technology

• Internal
• External

By Biomaterial

• Metallic
• Polymeric
• Ceramic

By Application

• Chronic Pain
• Urinary & Fecal Incontinence
• Migraine
• Failed Back Syndrome
• Parkinson Disease
• Epilepsy
• Tremor
• Depression
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Medtronic PLC
• LivaNova PLC
• Boston Scientific Corporation
• Abbott Laboratories
• Nevro Corporation
• NeuroSigma, Inc.
• NeuroPace, Inc.
• Neuronetics, Inc.
• MicroTransponder Inc.
• Bioventus Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Neuromodulation Market, by Technology
1.4.2 LAMEA Neuromodulation Market, by Biomaterial
1.4.3 LAMEA Neuromodulation Market, by Application
1.4.4 LAMEA Neuromodulation Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Approvals and Trials
3.2.3 Product Launches and Product Expansions
3.2.4 Acquisition and Mergers
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. LAMEA Neuromodulation Market by Technology
4.1 LAMEA Internal Market by Country
4.2 LAMEA External Market by Country

Chapter 5. LAMEA Neuromodulation Market by Biomaterial
5.1 LAMEA Metallic Market by Country
5.2 LAMEA Polymeric Market by Country
5.3 LAMEA Ceramic Market by Country

Chapter 6. LAMEA Neuromodulation Market by Application
6.1 LAMEA Chronic Pain Market by Country
6.2 LAMEA Urinary & Fecal Incontinence Market by Country
6.3 LAMEA Migraine Market by Country
6.4 LAMEA Failed Back Syndrome Market by Country
6.5 LAMEA Parkinson Disease Market by Country
6.6 LAMEA Epilepsy Market by Country
6.7 LAMEA Tremor Market by Country
6.8 LAMEA Depression Market by Country
6.9 LAMEA Others Market by Country

Chapter 7. LAMEA Neuromodulation Market by Country
7.1 Brazil Neuromodulation Market
7.1.1 Brazil Neuromodulation Market by Technology
7.1.2 Brazil Neuromodulation Market by Biomaterial
7.1.3 Brazil Neuromodulation Market by Application
7.2 Argentina Neuromodulation Market
7.2.1 Argentina Neuromodulation Market by Technology
7.2.2 Argentina Neuromodulation Market by Biomaterial
7.2.3 Argentina Neuromodulation Market by Application
7.3 UAE Neuromodulation Market
7.3.1 UAE Neuromodulation Market by Technology
7.3.2 UAE Neuromodulation Market by Biomaterial
7.3.3 UAE Neuromodulation Market by Application
7.4 Saudi Arabia Neuromodulation Market
7.4.1 Saudi Arabia Neuromodulation Market by Technology
7.4.2 Saudi Arabia Neuromodulation Market by Biomaterial
7.4.3 Saudi Arabia Neuromodulation Market by Application
7.5 South Africa Neuromodulation Market
7.5.1 South Africa Neuromodulation Market by Technology
7.5.2 South Africa Neuromodulation Market by Biomaterial
7.5.3 South Africa Neuromodulation Market by Application
7.6 Nigeria Neuromodulation Market
7.6.1 Nigeria Neuromodulation Market by Technology
7.6.2 Nigeria Neuromodulation Market by Biomaterial
7.6.3 Nigeria Neuromodulation Market by Application
7.7 Rest of LAMEA Neuromodulation Market
7.7.1 Rest of LAMEA Neuromodulation Market by Technology
7.7.2 Rest of LAMEA Neuromodulation Market by Biomaterial
7.7.3 Rest of LAMEA Neuromodulation Market by Application

Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.2 LivaNova PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Approvals and Trials:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Geographical Expansions:
8.4 Abbott Laboratories
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Nevro Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals and Trials:
8.6 NeuroSigma, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 NeuroPace, Inc.
8.7.1 Company Overview
8.7.2 Recent Strategies and Developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Neuronetics, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.9 MicroTransponder Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Approvals and Trials:
8.10. Bioventus Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Approvals and Trials:
8.10.5.2 Acquisition and Mergers:

TABLE 1 LAMEA Neuromodulation Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Neuromodulation Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Neuromodulation Market
TABLE 4 Approvals and Trials - NEUROMODULATION MARKET
TABLE 5 Product Launches And Product Expansions– Neuromodulation Market
TABLE 6 Acquisition and Mergers– Neuromodulation Market
TABLE 7 Geographical Expansions- Neuromodulation Market
TABLE 8 LAMEA Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 9 LAMEA Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 10 LAMEA Internal Market by Country, 2018 - 2021, USD Million
TABLE 11 LAMEA Internal Market by Country, 2022 - 2028, USD Million
TABLE 12 LAMEA External Market by Country, 2018 - 2021, USD Million
TABLE 13 LAMEA External Market by Country, 2022 - 2028, USD Million
TABLE 14 LAMEA Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 15 LAMEA Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 16 LAMEA Metallic Market by Country, 2018 - 2021, USD Million
TABLE 17 LAMEA Metallic Market by Country, 2022 - 2028, USD Million
TABLE 18 LAMEA Polymeric Market by Country, 2018 - 2021, USD Million
TABLE 19 LAMEA Polymeric Market by Country, 2022 - 2028, USD Million
TABLE 20 LAMEA Ceramic Market by Country, 2018 - 2021, USD Million
TABLE 21 LAMEA Ceramic Market by Country, 2022 - 2028, USD Million
TABLE 22 LAMEA Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 23 LAMEA Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 24 LAMEA Chronic Pain Market by Country, 2018 - 2021, USD Million
TABLE 25 LAMEA Chronic Pain Market by Country, 2022 - 2028, USD Million
TABLE 26 LAMEA Urinary & Fecal Incontinence Market by Country, 2018 - 2021, USD Million
TABLE 27 LAMEA Urinary & Fecal Incontinence Market by Country, 2022 - 2028, USD Million
TABLE 28 LAMEA Migraine Market by Country, 2018 - 2021, USD Million
TABLE 29 LAMEA Migraine Market by Country, 2022 - 2028, USD Million
TABLE 30 LAMEA Failed Back Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 31 LAMEA Failed Back Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 32 LAMEA Parkinson Disease Market by Country, 2018 - 2021, USD Million
TABLE 33 LAMEA Parkinson Disease Market by Country, 2022 - 2028, USD Million
TABLE 34 LAMEA Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 35 LAMEA Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 36 LAMEA Tremor Market by Country, 2018 - 2021, USD Million
TABLE 37 LAMEA Tremor Market by Country, 2022 - 2028, USD Million
TABLE 38 LAMEA Depression Market by Country, 2018 - 2021, USD Million
TABLE 39 LAMEA Depression Market by Country, 2022 - 2028, USD Million
TABLE 40 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 41 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 42 LAMEA Neuromodulation Market by Country, 2018 - 2021, USD Million
TABLE 43 LAMEA Neuromodulation Market by Country, 2022 - 2028, USD Million
TABLE 44 Brazil Neuromodulation Market, 2018 - 2021, USD Million
TABLE 45 Brazil Neuromodulation Market, 2022 - 2028, USD Million
TABLE 46 Brazil Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 47 Brazil Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 48 Brazil Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 49 Brazil Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 50 Brazil Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 51 Brazil Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 52 Argentina Neuromodulation Market, 2018 - 2021, USD Million
TABLE 53 Argentina Neuromodulation Market, 2022 - 2028, USD Million
TABLE 54 Argentina Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 55 Argentina Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 56 Argentina Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 57 Argentina Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 58 Argentina Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 59 Argentina Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 60 UAE Neuromodulation Market, 2018 - 2021, USD Million
TABLE 61 UAE Neuromodulation Market, 2022 - 2028, USD Million
TABLE 62 UAE Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 63 UAE Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 64 UAE Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 65 UAE Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 66 UAE Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 67 UAE Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 68 Saudi Arabia Neuromodulation Market, 2018 - 2021, USD Million
TABLE 69 Saudi Arabia Neuromodulation Market, 2022 - 2028, USD Million
TABLE 70 Saudi Arabia Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 71 Saudi Arabia Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 72 Saudi Arabia Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 73 Saudi Arabia Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 74 Saudi Arabia Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 75 Saudi Arabia Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 76 South Africa Neuromodulation Market, 2018 - 2021, USD Million
TABLE 77 South Africa Neuromodulation Market, 2022 - 2028, USD Million
TABLE 78 South Africa Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 79 South Africa Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 80 South Africa Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 81 South Africa Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 82 South Africa Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 83 South Africa Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 84 Nigeria Neuromodulation Market, 2018 - 2021, USD Million
TABLE 85 Nigeria Neuromodulation Market, 2022 - 2028, USD Million
TABLE 86 Nigeria Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 87 Nigeria Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 88 Nigeria Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 89 Nigeria Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 90 Nigeria Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 91 Nigeria Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 92 Rest of LAMEA Neuromodulation Market, 2018 - 2021, USD Million
TABLE 93 Rest of LAMEA Neuromodulation Market, 2022 - 2028, USD Million
TABLE 94 Rest of LAMEA Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 95 Rest of LAMEA Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 96 Rest of LAMEA Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 97 Rest of LAMEA Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 98 Rest of LAMEA Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 99 Rest of LAMEA Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 100 Key Information – Medtronic PLC
TABLE 101 Key Information – LivaNova PLC
TABLE 102 key Information – Boston Scientific Corporation
TABLE 103 Key Information – Abbott Laboratories
TABLE 104 Key Information – Nevro Corporation
TABLE 105 key Information – NeuroSigma, Inc.
TABLE 106 Key Information – NeuroPace, Inc.
TABLE 107 Key Information – Neuronetics, Inc.
TABLE 108 Key Information – MicroTransponder Inc.
TABLE 109 Key Information – Bioventus Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Medtronic PLC
FIG 5 Recent strategies and developments: Bioventus Inc.